Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy

Assessing treatment adherence is crucial to determine adequacy of mineralocorticoid therapy

Background: There is no consensus strategy for mineralocorticoid (MC) therapy titration in patients with primary adrenal insufficiency (PAI). W e aim to measure serum fludrocortisone (sFC) and urine fludrocortisone (uFC) levels and to determine their utility, alongside clinical/biochemical variables...

Full description

Bibliographic Details
Main Authors: Riccardo Pofi, Ilaria Bonaventura, Joanne Duffy, Zoe Maunsell, Brian Shine, Andrea M Isidori, Jeremy W Tomlinson
Format: Article
Language:English
Published: Bioscientifica 2023-08-01
Series:Endocrine Connections
Subjects:
mineralocorticoids
glucocorticoids
congenital adrenal hyperplasia
addison’s disease
renin
Online Access:https://ec.bioscientifica.com/view/journals/ec/12/9/EC-23-0059.xml

Internet

https://ec.bioscientifica.com/view/journals/ec/12/9/EC-23-0059.xml

Similar Items